SURVIVAL OF PATIENTS WITH RECTAL CANCER

Author:

Tataryn Bohdan1,Kryzhanivska Anna1,Dyakiv Iryna1,Andriiv Alina1

Affiliation:

1. IVANO-FRANKIVSK NATIONAL MEDICAL UNIVERSITY, IVANO-FRANKIVSK, UKRAINE

Abstract

The aim: To evaluate the early and late results of treatment of rectal cancer patients after special treatment methods with a view to indentifying optimal method of treatment in correlation with the stage of the disease. Materials and methods: The study is based on the results of observation of 779 patients with stage II, III and IV rectal cancer (RC) who were divided into groups according to the treatment (surgery, surgery + chemotherapy, chemotherapy, surgery + chemotherapy + radiation therapy, radiation therapy + surgery, radiation therapy). Results: According to the results obtained, the overall survival of patients correlates with the stage of rectal cancer: we see the highest percentage of patients’ survival in stage II and, accordingly, the lowest – in stage IV in each of the studied time intervals. Conclusions: The use of combined and integrated treatment in patients with stages II and stage III and the use of chemotherapy in stage IV RC gives a higher rate of cumulative survival of patients at each of the studied intervals

Publisher

ALUNA

Subject

General Medicine

Reference16 articles.

1. 1. Jamal A., Cancer C.A., Clin J. et al. Global cancer statistics. 2013;63:11–30.

2. 2. Fedorenko Z.P., Mykhailovych Yu.Y., Gulak L.O. et al. Rak v Ukraini 2017-2018 [Cancer in Ukraine 2017-2018]. Biul.Nats.Kantser-reiestruUkrainy. 2019; 17:144. (In Ukrainian).

3. 3. Tyuliandin C.A., Moiseyenko V.M. Prakticheskaia Onkolohia: izbrannye lektsii [Practical Oncology: selected lectures]. ТОММ tsentr. 2004. (In Ukrainian).

4. 4. Kornek G., Scheithauer W., Anghel R. et al. Konsensus shchodo medykamentoznoho likuvannia raku [Consencus of medication-based treatment of rectal cancer]. Medytsyna svitu. 2008; 1(6):79–90. (In Ukrainian).

5. 5. Tataryn B.B., Kryzhanivska A.E., Holotiuk І.S. et al. Factors of prognosis in rectal cancer patients. Оncology. 2019; 3(81): 245 – 250.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3